explore -WSS

explore

author：entertainment 2025-09-14 18:33:01 - browse：35978

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Covid vaccine financial winners and losers, from Pfizer to Novavax

WSS

Cord blood banking comes at a high cost to babies

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Merck drug for rare lung condition set for approval in U.S.

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Ionis drug prevents swelling attacks due to hereditary angioedema

Intellia reports positive results for its CRISPR

entertainment

explore

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

HIV drugs protect against transmission, even in unprotected sex

United colonoscopy coverage change 'may cost lives,' doctors say

ASCO: AstraZeneca says CAR

Jerome Adams on the need for new antivirals for Covid

Patient advocates debate FDA's accelerated approval process

Anesthesiologist group: stop taking Ozempic before surgery

Scientists boost immune system in aging mice by making it youthful

In age of alternative facts, a scholarly course on calling out crap

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

hotspot

Readout LOUD podcast: mifepristone case, GLP

Let's speed up science by embracing open access publishing

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Roche subsidiary Foundation Medicine opens new headquarters

Cord blood banking comes at a high cost to babies

There's no autism epidemic. It's an autism diagnosis epidemic

hotspot

Wikipedia

hotspot

explore